Lewis Tanya Insider Trades

Insider Trading History

Track insider trading activity for Lewis Tanya. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
DiaMedica Therapeutics
DiaMedica Therapeutics DMAC
Director
Holding Value $188k 32,162 shares
Last Trade
Jun 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$132k 32,162 shares
$4.11
$5.84
DiaMedica Therapeutics
DiaMedica Therapeutics DMAC
Director
Holding Value $166k 28,472 shares
Last Trade
Jun 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.6k 28,472 shares
$2.90
$5.84
Replimune Group
Replimune Group REPL
Chief Dev. Op. Officer
Holding Value $1.34M 136,110 shares
Last Trade
Jun 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$309k 12,860 shares
$24.06
$9.87
DiaMedica Therapeutics
DiaMedica Therapeutics DMAC
Director
Holding Value $43.8k 7,493 shares
Last Trade
Jun 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.5k 7,493 shares
$2.73
$5.84
Replimune Group
Replimune Group REPL
Chief Dev. Op. Officer
Holding Value $1.46M 148,153 shares
Last Trade
May 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$220k 12,207 shares
$18.05
$9.87
Replimune Group
Replimune Group REPL
Chief Dev. Op. Officer
Holding Value $1.58M 160,360 shares
Last Trade
Apr 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.77M 100,000 shares
$17.66
$9.87
DiaMedica Therapeutics
DiaMedica Therapeutics DMAC
Director
Holding Value $154k 26,443 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$46.8k 26,443 shares
$1.77
$5.84
Replimune Group
Replimune Group REPL
Chief Dev. Op Officer
Holding Value $1.19M 120,360 shares
Last Trade
May 16, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$79.9k 5,473 shares
$14.59
$9.87
Replimune Group
Replimune Group REPL
Chief Dev.op Off
Holding Value $1.24M 125,833 shares
Last Trade
Apr 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.83M 210,000 shares
$18.26
$9.87
Replimune Group
Replimune Group REPL
Chief Dev. Oper. Off.
Holding Value $1.09M 110,000 shares
Last Trade
May 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.23M 183,333 shares
$33.99
$9.87
Replimune Group
Replimune Group REPL
Director
Holding Value $163k 16,500 shares
Last Trade
Apr 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$521k 16,500 shares
$31.58
$9.87
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Evp, Chief Reg. Affairs
Holding Value $544k 59,968 shares
Last Trade
Feb 25, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.9M 81,981 shares
$218.40
$9.07
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Evp, Chief Reg. Affairs
Holding Value $37.6k 4,143 shares
Last Trade
Feb 11, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$471k 2,046 shares
$230.25
$9.07
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Evp, Chief Reg. Affairs
Holding Value $154k 16,950 shares
Last Trade
Feb 05, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.37M 5,650 shares
$242.63
$9.07
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Evp, Chief Reg. Affairs
Holding Value $56.1k 6,189 shares
Last Trade
Feb 05, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.37M 5,650 shares
$242.63
$9.07
Replimune Group
Replimune Group REPL
Director
Holding Value $326k 33,000 shares
Last Trade
Nov 02, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.39M 33,000 shares
$42.00
$9.87
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Evp,chief Reg.&quality Officer
Holding Value $4.89k 539 shares
Last Trade
Oct 30, 2020 Sale (Open Market)Shares sold on the open market or in a private sale.
$50.2k 226 shares
$222.30
$9.07
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Evp,chief Reg.&quality Officer
Holding Value $20.8k 2,295 shares
Last Trade
Oct 28, 2020 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$178k 765 shares
$232.20
$9.07
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Evp,chief Reg.&quality Officer
Holding Value $6.94k 765 shares
Last Trade
Oct 28, 2020 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$178k 765 shares
$232.20
$9.07
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Evp,chief Reg.&quality Officer
Holding Value $550k 60,600 shares
Last Trade
Feb 05, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.5M 83,200 shares
$270.08
$9.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up